Johnson & Johnson has reached a landmark settlement of $5.5 billion to resolve claims from approximately 76,000 plaintiffs who alleged that the company's talcum powder products were responsible for causing ovarian cancer. This major agreement represents one of the largest product liability settlements in pharmaceutical history and addresses decades-long litigation regarding the safety of talc-based personal care items. The resolution underscores growing concerns about potential health risks associated with talc exposure and reflects the company's decision to conclude protracted legal battles.

Summary auto-generated by AI from the original publisher's content. Editorial standards.